BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8398813)

  • 1. Expression of beta 2-microglobulin by human benign and malignant mesenchymal and neurogenic tumours.
    Petersen BL; Braendstrup O
    Int J Exp Pathol; 1993 Aug; 74(4):397-401. PubMed ID: 8398813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors.
    Palman C; Bowen-Pope DF; Brooks JJ
    Lab Invest; 1992 Jan; 66(1):108-15. PubMed ID: 1309926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-2-microglobulin in benign and malignant adnexal skin tumors and metastasizing basocellular carcinomas.
    Kallioinen M; Dammert K
    J Cutan Pathol; 1984 Feb; 11(1):27-34. PubMed ID: 6365986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
    Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
    J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of beta 2-microglobulin in human breast carcinoma.
    Weiss MA; Michael JG; Pesce AJ; DiPersio L
    Lab Invest; 1981 Jul; 45(1):46-57. PubMed ID: 6166789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of beta 2 microglobulin in malignant tumors of the ovaries].
    Kudela M; Fischerová E; Hansmanová L
    Cesk Gynekol; 1989 Jun; 54(5):341-4. PubMed ID: 2676201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2-microglobulin in squamous cell carcinomas of the head and neck and in tumours heterotransplanted into nude athymic mice.
    Wennerberg J; Alm P; Lögdberg L; Tropé C
    Acta Otolaryngol; 1984; 98(3-4):335-42. PubMed ID: 6388230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.
    Ruiter DJ; Bhan AK; Harrist TJ; Sober AJ; Mihm MC
    J Immunol; 1982 Dec; 129(6):2808-15. PubMed ID: 6183345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta 2-microglobulin in non-malignant and malignant human breast: a feature of differentiation.
    Sidky K; Walker RA
    J Pathol; 1984 Feb; 142(2):135-40. PubMed ID: 6366179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the beta 2-microglobulin levels of the blood serum in patients with benign and malignant neoplasms].
    Chebotareva ED; Shishkina VV; Siniuta BF; Sagan DL; Zamiatin SS; Balitskaia OV; Putseva NM; Leonova EB; Goroshko VM
    Vrach Delo; 1991 Aug; (8):66-70. PubMed ID: 1949740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mesenchymal (non-epithelial) salivary gland tumors. Analysis of 167 tumor cases of the salivary gland register].
    Seifert G; Oehne H
    Laryngol Rhinol Otol (Stuttg); 1986 Sep; 65(9):485-91. PubMed ID: 3784727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial sarcoma: an immunohistochemical study.
    Salisbury JR; Isaacson PG
    J Pathol; 1985 Sep; 147(1):49-57. PubMed ID: 2995626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 expression is a common molecular event in soft tissue sarcomas.
    Murray GI; McKay JA; Weaver RJ; Ewen SW; Melvin WT; Burke MD
    J Pathol; 1993 Sep; 171(1):49-52. PubMed ID: 8229456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical staining for apolipoprotein B in human sarcomas.
    Dekmezian R; Zaatari GS; Austin GE
    Arch Pathol Lab Med; 1987 May; 111(5):433-5. PubMed ID: 3032125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndecan-1 expression in different soft tissue tumours.
    Orosz Z; Kopper L
    Anticancer Res; 2001; 21(1B):733-7. PubMed ID: 11299835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanisms for the elevation of serum beta 2-microglobulin levels in adult T-cell leukemia.
    Tsuda H; Sawada T; Sakata KM; Takatsuki K
    Int J Hematol; 1992 Apr; 55(2):179-87. PubMed ID: 1511167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
    Bhan AK; DesMarais CL
    J Natl Cancer Inst; 1983 Sep; 71(3):507-16. PubMed ID: 6193308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
    J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal stromal tumours: evaluation of biological and clinical current opinions.
    Adani GL; Marcello D; Sanna A; Mazzetti J; Anania G; Donini A
    Chir Ital; 2002; 54(2):127-31. PubMed ID: 12038102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
    Ramasami S; Kerr KM; Chapman AD; King G; Cockburn JS; Jeffrey RR
    J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.